Neuralink's "Blindsight" device, developed by Elon Musk's company, aims to restore vision for blind individuals.
AstraZeneca's Saphnelo has become the first new drug to be approved to treat the autoimmune disease systemic lupus erythematosus (SLE) in the EU for more than 10 years.
Sep. 18, 2024 — People whose diet more closely resembles the MIND diet may have a lower risk of cognitive impairment, according to a new study. Results were similar for Black and white ...